• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合多糖疫苗的免疫原性及纯化方法分析:对抗病原菌的新方法

Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria.

作者信息

Sheikhi Arya, Shirmohammadpour Mina, Mahdei Nasirmahalleh Nima, Mirzaei Bahman

机构信息

Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran.

Student Research Committee, Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

出版信息

Front Immunol. 2024 Nov 20;15:1483740. doi: 10.3389/fimmu.2024.1483740. eCollection 2024.

DOI:10.3389/fimmu.2024.1483740
PMID:39635523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614811/
Abstract

Carbohydrates are commonly found in conjunction with lipids or proteins, resulting in the formation of glycoconjugates such as glycoproteins, glycolipids, and proteoglycans. These glycoconjugates are essential in various biological activities, including inflammation, cell-cell recognition, bacterial infections, and immune response. Nonetheless, the isolation of naturally occurring glycoconjugates presents challenges due to their typically heterogeneous nature, resulting in variations between batches in structure and function, impeding a comprehensive understanding of their mechanisms of action. Consequently, there is a strong need for the efficient synthesis of artificial glycoconjugates with precisely described compositions and consistent biological properties. The chemical and enzymatic approaches discussed in this paper present numerous research opportunities to develop customised glycoconjugate vaccines.

摘要

碳水化合物通常与脂质或蛋白质结合存在,从而形成糖缀合物,如糖蛋白、糖脂和蛋白聚糖。这些糖缀合物在多种生物活性中至关重要,包括炎症、细胞间识别、细菌感染和免疫反应。然而,由于天然存在的糖缀合物通常具有异质性,导致批次之间在结构和功能上存在差异,阻碍了对其作用机制的全面理解,因此分离它们具有挑战性。因此,迫切需要高效合成具有精确描述的组成和一致生物学特性的人工糖缀合物。本文讨论的化学和酶促方法为开发定制化糖缀合物疫苗提供了众多研究机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/d3429df4aab8/fimmu-15-1483740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/d0ee5b62bed9/fimmu-15-1483740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/e92c47db41b5/fimmu-15-1483740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/c17692eda7b8/fimmu-15-1483740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/c292564bfa08/fimmu-15-1483740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/fecc1eb3bc85/fimmu-15-1483740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/d3429df4aab8/fimmu-15-1483740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/d0ee5b62bed9/fimmu-15-1483740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/e92c47db41b5/fimmu-15-1483740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/c17692eda7b8/fimmu-15-1483740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/c292564bfa08/fimmu-15-1483740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/fecc1eb3bc85/fimmu-15-1483740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d97/11614811/d3429df4aab8/fimmu-15-1483740-g006.jpg

相似文献

1
Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria.结合多糖疫苗的免疫原性及纯化方法分析:对抗病原菌的新方法
Front Immunol. 2024 Nov 20;15:1483740. doi: 10.3389/fimmu.2024.1483740. eCollection 2024.
2
Synthetic carbohydrate-based vaccines: challenges and opportunities.合成碳水化合物疫苗:挑战与机遇。
J Biomed Sci. 2020 Jan 3;27(1):9. doi: 10.1186/s12929-019-0591-0.
3
[Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].[碳水化合物与疫苗:从纯化多糖到半合成糖缀合物疫苗]
Ann Pharm Fr. 2007 Jan;65(1):14-32. doi: 10.1016/s0003-4509(07)90014-0.
4
Glycoconjugate vaccines: some observations on carrier and production methods.糖缀合物疫苗:关于载体和生产方法的一些观察。
Biotechnol Genet Eng Rev. 2019 Oct;35(2):93-125. doi: 10.1080/02648725.2019.1703614. Epub 2020 Feb 12.
5
Glycoconjugate vaccines: current approaches towards faster vaccine design.糖缀合物疫苗:更快疫苗设计的当前方法。
Expert Rev Vaccines. 2019 Sep;18(9):881-895. doi: 10.1080/14760584.2019.1657012. Epub 2019 Aug 31.
6
Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.推进同质抗菌糖缀合物疫苗。
Acc Chem Res. 2017 May 16;50(5):1270-1279. doi: 10.1021/acs.accounts.7b00106. Epub 2017 May 2.
7
Improving vaccines against using synthetic glycans.利用合成糖脂改进疫苗。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13353-13358. doi: 10.1073/pnas.1811862115. Epub 2018 Dec 7.
8
Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates.稀有去氧氨基糖的化学合成,包含细菌糖缀合物作为潜在疫苗候选物。
Molecules. 2018 Aug 10;23(8):1997. doi: 10.3390/molecules23081997.
9
Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.探索连接位点和化学性质对基于B群链球菌67型菌毛蛋白和Ⅴ型多糖的抗B群链球菌糖共轭疫苗免疫原性的影响。
Bioconjug Chem. 2015 Aug 19;26(8):1839-49. doi: 10.1021/acs.bioconjchem.5b00365. Epub 2015 Jul 31.
10
Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.糖缀合物用于疫苗开发的最新进展。
Molecules. 2018 Jul 13;23(7):1712. doi: 10.3390/molecules23071712.

本文引用的文献

1
Novel manufacturing process of pneumococcal capsular polysaccharides using advanced sterilization methods.采用先进灭菌方法的肺炎球菌荚膜多糖新型制造工艺。
Front Bioeng Biotechnol. 2024 Aug 7;12:1451881. doi: 10.3389/fbioe.2024.1451881. eCollection 2024.
2
Impact of Protein Nanoparticle Shape on the Immunogenicity of Antimicrobial Glycoconjugate Vaccines.蛋白质纳米颗粒形状对抗菌糖缀合物疫苗免疫原性的影响。
Int J Mol Sci. 2024 Mar 27;25(7):3736. doi: 10.3390/ijms25073736.
3
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial.
新型 24 价肺炎球菌疫苗在幼儿中的安全性、耐受性和免疫原性:一项 1 期随机对照试验。
Vaccine. 2024 Apr 11;42(10):2560-2571. doi: 10.1016/j.vaccine.2024.02.001. Epub 2024 Feb 14.
4
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial.评估一种 24 价肺炎球菌结合疫苗(VAX-24)在 18 至 64 岁健康成年人中的安全性、耐受性和免疫原性:一项 1/2 期、双盲、剂量探索、主动对照、随机临床试验。
Lancet Infect Dis. 2024 Mar;24(3):308-318. doi: 10.1016/S1473-3099(23)00572-8. Epub 2023 Dec 4.
5
Genetic Engineering of ATCC 25955 for Bioconjugate Vaccine Applications.用于生物偶联疫苗应用的美国典型培养物保藏中心25955的基因工程
Microorganisms. 2023 May 17;11(5):1321. doi: 10.3390/microorganisms11051321.
6
Carriers and Antigens: New Developments in Glycoconjugate Vaccines.载体与抗原:糖缀合物疫苗的新进展
Vaccines (Basel). 2023 Jan 19;11(2):219. doi: 10.3390/vaccines11020219.
7
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.基于细菌多糖重复单元的抗菌结合疫苗概念的发展。
ACS Infect Dis. 2023 Feb 10;9(2):178-212. doi: 10.1021/acsinfecdis.2c00559. Epub 2023 Jan 27.
8
Maturation of Aluminium Adsorbed Antigens Contributes to the Creation of Homogeneous Vaccine Formulations.铝吸附抗原的成熟有助于制备均匀的疫苗制剂。
Vaccines (Basel). 2023 Jan 11;11(1):155. doi: 10.3390/vaccines11010155.
9
Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine.一种肺炎球菌生物结合疫苗的免疫原性和保护效力。
Vaccine. 2022 Oct 6;40(42):6107-6113. doi: 10.1016/j.vaccine.2022.09.018. Epub 2022 Sep 15.
10
Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response.经典疫苗和生物偶联疫苗:结构特性和免疫应答的比较。
Curr Opin Immunol. 2022 Oct;78:102235. doi: 10.1016/j.coi.2022.102235. Epub 2022 Aug 18.